纳斯达克： -- -- --

最近浏览

实时行情

意见反馈

精密科学

NASDAQ:EXAS 延时15分钟
  • 今开：--
    昨收：--
  • 今日区间：--
    52周区间：--
  • 成交量：--
    成交额：--
  • 市 值：--
    市盈率：--
  • 振幅：
    每股收益：
成交量

董事会

Kevin T. Conroy
Kevin T. Conroy is Chairman, President & Chief Executive Officer at EXACT Sciences Corp. since 2014, Chief Executive Officer at Genomic Health, Inc. since 2019, Independent Director at Align Technology, Inc. since 2023, President & Director at Paradigm Diagnostics, Inc., Director at Wisconsin Technology Council, Treasurer & Director at American Clinical Laboratory Association, Director at Greater Madison Chamber of Commerce, Director at LetsGetChecked, Inc. since 2024, and Director at Overture Center Foundation. Former roles include President & Chief Executive Officer at Third Wave Technologies, Inc. from 2005 to 2008, Chairman at United Way of Dane County, Inc., Director at Bioforward, Inc., Independent Director at Epizyme, Inc. from 2017 to 2022, Independent Director at Adaptive Biotechnologies Corp. from 2019 to 2023, Independent Director at CM Life Sciences II, Inc. in 2021, Director at Overture Center For The Arts, Independent Director at SomaLogic, Inc., Independent Director at ARYA Sciences Acquisition Corp. from 2018 to 2020, Partner at McDermott Will & Emery LLP, Partner at Pattishall, McAuliffe, Newbury, Hilliard & Geraldson LLP, and Counsel-Intellectual Property at GE Healthcare Ltd. (United Kingdom) from 2002 to 2004. Education includes undergraduate studies at Michigan State University and graduate studies at The University of Michigan Law School.
旧服务已下线，请迁移至 http://api.fanyi.baidu.com
Kevin T. Conroy
Kevin T. Conroy is Chairman, President & Chief Executive Officer at EXACT Sciences Corp. since 2014, Chief Executive Officer at Genomic Health, Inc. since 2019, Independent Director at Align Technology, Inc. since 2023, President & Director at Paradigm Diagnostics, Inc., Director at Wisconsin Technology Council, Treasurer & Director at American Clinical Laboratory Association, Director at Greater Madison Chamber of Commerce, Director at LetsGetChecked, Inc. since 2024, and Director at Overture Center Foundation. Former roles include President & Chief Executive Officer at Third Wave Technologies, Inc. from 2005 to 2008, Chairman at United Way of Dane County, Inc., Director at Bioforward, Inc., Independent Director at Epizyme, Inc. from 2017 to 2022, Independent Director at Adaptive Biotechnologies Corp. from 2019 to 2023, Independent Director at CM Life Sciences II, Inc. in 2021, Director at Overture Center For The Arts, Independent Director at SomaLogic, Inc., Independent Director at ARYA Sciences Acquisition Corp. from 2018 to 2020, Partner at McDermott Will & Emery LLP, Partner at Pattishall, McAuliffe, Newbury, Hilliard & Geraldson LLP, and Counsel-Intellectual Property at GE Healthcare Ltd. (United Kingdom) from 2002 to 2004. Education includes undergraduate studies at Michigan State University and graduate studies at The University of Michigan Law School.
旧服务已下线，请迁移至 http://api.fanyi.baidu.com
Katherine Zanotti
Katherine Zanotti currently works at EXACT Sciences Corp., as Independent Director from 2009, Diversey, Inc., as Director, Maple Mountain Group, Inc., as Director from 2023, RxDino LLC, as Director, and Xavier University, as Trustee from 2014. Ms. Zanotti also formerly worked at Arbonne International LLC, as Chief Executive Officer from 2009 to 2018, Natural Products Group, Inc., as Chairman from 2010 to 2018, Mentor Worldwide LLC, as Director from 2007 to 2009, Third Wave Technologies, Inc., as Director from 2006 to 2008, Cutera, Inc., as Independent Director from 2019 to 2022, Hill-Rom Holdings, Inc., as Independent Director from 2009 to 2013, Catholic Health Care System, as Director, Alberto-Culver LLC, as Director from 2006 to 2009, Diversey Holdings Ltd. (Cayman Islands), as Independent Director from 2022 to 2023, McDonald's Corp., as Senior Vice President-Marketing from 2002 to 2006, and Procter & Gamble Co., as VP & GM-North American Pharmaceutical Business from 1997 to 2002. Ms. Zanotti received her Masters Business Admin degree from Xavier University and undergraduate degree from Georgetown University.
Daniel Joseph Levangie
Daniel Joseph Levangie was the founder of Constitution Medical, Inc. (2008) as Director & Managing Partner, Aton Partners LLC (2013) as Managing Partner, and CereVasc, Inc. (2018) as Chairman, President & Chief Executive Officer. Current jobs include Independent Director at EXACT Sciences Corp. (2010), Director at Rapid Medical Ltd. (2021), and Trustee at Excel Academy Charter School. Former jobs include Chief Executive Officer at Dune Medical Devices, Inc. (2011-2013), Non-Executive Chairman at ev3, Inc. (2007-2010), Chairman at Keystone Dental, Inc. (2009-2011), Chairman at HyperMed, Inc., Independent Director at LipoScience, Inc. (2011-2014), Director at Renovia, Inc. (MA), Director at Hologic, Inc. (2007-2009), Independent Non-Executive Director at Renalytix Plc (2021-2024), Principal at Abbott Laboratories (1975-1992), President, Chief Executive & Operating Officer at Cytyc Corp. (2002-2007), and President-Drug Delivery Division at Insulet Corp. (2015-2017). Education includes an undergraduate degree from Northeastern University (1973).
James Edward Doyle
James Edward Doyle currently works at EXACT Sciences Corp., as Lead Independent Director, Foley & Lardner LLP, as Of Counsel from 2011, and Doyle & Boyce Strategies LLC, as Partner from 2011. Mr. Doyle also formerly worked at County of Dane (Wisconsin), as District Attorney from 1977 to 1982, State of Wisconsin, as Governor from 2003 to 2011, Navajo Nation, as Attorney, and National Association of Attorneys General, as President from 1997 to 1998. Mr. Doyle received his undergraduate degree from the University of Wisconsin and graduate degree from Harvard Law School.
旧服务已下线，请迁移至 http://api.fanyi.baidu.com
D. Scott Coward
D. Scott Coward currently works at EXACT Sciences Corp., as Director from 2022, Paradigm Diagnostics, Inc., as Secretary & Director, Wisconsin Technology Council, as Director, College of Charleston, as Professor from 2023, and The North Carolina Bar Association, as Member. Mr. Coward also formerly worked at Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan LLP, as Partner from 1991 to 2002, GE Medical Systems Information Systems, as Associate General Counsel from 2002 to 2003, Blue Rhino Corp., as Secretary & General Counsel from 2003 to 2004, K&L Gates LLP, as Managing Partner-Raleigh from 2013 to 2014, and Genomic Health, Inc., as Secretary. Mr. Coward received his undergraduate degree from The University of North Carolina at Chapel Hill and graduate degree from Columbia Law School.
Shacey Petrovic
Shacey Petrovic is currently serving as Vice Chairman at Ambu A and Vice Chairman at Imperative Care, Inc. She is also Chairman at Novocuff, Inc. Additionally, she holds positions as an Independent Director at EXACT Sciences Corp., Director at Advanced Medical Technology Association, Director at Alydia Health, Inc., and Director at Axena Health, Inc. In her former roles, Ms. Petrovic served as President & Chief Executive Officer at Clinical Innovations LLC from 2013 to 2015. She was also a Director at Insulet Corp. from 2015 to 2024. Prior to that, she held the position of Vice President & GM-GYN Surgical Products Division at Hologic, Inc. from 2000 to 2013, and at Cytyc Corp. from 2000 to 2007. Ms. Petrovic completed her undergraduate degree at the University of Wisconsin in 1996.
Paul J. Clancy
Paul J. Clancy is currently Independent Non-Executive Chairman at Sionna Therapeutics, Inc. since 2022. He is an Independent Director at Incyte Corp. since 2015 and at EXACT Sciences Corp. since 2021. He also serves as Secretary, Director & Vice President at Stromedix, Inc. Formerly, Mr. Clancy was Chairman at Xilio Therapeutics, Inc. from 2022 to 2026. He was President & Director at Bioverativ Therapeutics, Inc. He served as Independent Director at Agios Pharmaceuticals, Inc. from 2013 to 2023. He was Chief Financial Officer & Executive VP-Finance at Biogen, Inc. from 2007 to 2017. He held the position of Chief Financial Officer & Executive Vice President at Biogen Idec New Ventures, Inc. He was Senior Vice President-Finance at Biogen Idec, Inc. (North Carolina). He was Executive Vice President at Alexion Pharmaceuticals, Inc. from 2019 to 2020. He was VP & General Manager-Great West Business Unit at PepsiCo, Inc. from 1997 to 2000. Education includes undergraduate studies at Babson College and an MBA from Columbia Business School.
Michael J. Barber
Mr. Michael J. Barber is an Independent Director at Dentsply Sirona, Inc., an Independent Director at EXACT Sciences Corp., an Executive Officer at Healthline Networks, Inc., a Chief Diversity Officer at GE Healthcare (Ventures) and a Member at National Academy of Engineering. He is on the Board of Directors at Dentsply Sirona, Inc., EXACT Sciences Corp. and The Green Bay Packers, Inc. Mr. Barber was previously employed as an Independent Director by Catalent, Inc., a Chief Diversity Officer by General Electric Co., and a Chief Technology Officer by GE Healthcare Ltd. (United Kingdom). He also served on the board at Talix, Inc., Healthline, Inc. and The National Action Council for Minorities in Engineering. He received his undergraduate degree from Milwaukee School of Engineering.
Kimberly J. Popovits
Kimberly J. Popovits currently serves as Independent Director at 10X Genomics, Inc. since 2020, Independent Director at Kiniksa Pharmaceuticals Ltd. since 2018, Lead Independent Director at Talis Biomedical Corp. since 2020, Independent Director at Kiniksa Pharmaceuticals International Plc starting 2024, and Independent Director at EXACT Sciences Corp. starting 2025. Additionally, holds director positions at American Clinical Laboratory Association, Personalized Medicine Coalition, California Biomedical Innovation Alliance, Kiniksa Pharmaceuticals Corp., California Life Sciences Association, Kardigan, Inc., Genomic Life, Inc., and The Coalition for 21st Century Medicine. Former roles include Chairman, President & Chief Executive Officer at Genomic Health, Inc. from 2012 to 2019, Vice Chairman at Nuvelo, Inc. from 2005 to 2009, Independent Director at ZS Pharma, Inc. in 2015, Independent Director at MyoKardia, Inc. from 2017 to 2020, Senior Vice President-Marketing & Sales at Genentech, Inc. from 2001 to 2002, Director at The Bay Area Bioscience Association, Division Manager-American Critical Care Division at American Hospital Supply Corp., and Division Manager-Southeast Region at American Critical Care Services, Inc. Education includes undergraduate studies at Michigan State University.
Leslie L. Trigg
Leslie L. Trigg is Chairman, President & Chief Executive Officer at Outset Medical, Inc. since 2022. Ms. Trigg is Director at The Medical Device Manufacturers Association. Ms. Trigg is Independent Director at ARYA Sciences Acquisition Corp. IV since 2021. Ms. Trigg is Independent Director at EXACT Sciences Corp. starting 2025. Ms. Trigg is Advisor at Vensana Capital Management LLC. Former roles include Director-Business Unit at Cytyc Corp. in 2002, Director-Market Development at Pro-Duct Health, Inc. in 2001, Independent Director at Cardiovascular Systems, Inc. from 2010 to 2017, Independent Director at Adaptive Biotechnologies Corp., Senior Manager-Product at Guidant Corp., Executive-in-Residence at Warburg Pincus LLC in 2014, Vice President-Marketing at FoxHollow Technologies, Inc. in 2006, Chief Business Officer, SVP-Sales & Marketing at Access Closure, Inc. from 2006 to 2009, and Executive VP-Marketing & Commercial Strategy at Lutonix, Inc. from 2010 to 2012. Education includes undergraduate studies at Northwestern University and an MBA from Haas School of Business.